Kathryn Dahir - Concepedia

Author

Kathryn Dahir

Vanderbilt University Medical Center ORCID

Also Known As

Dahir K, Janet Crane, K Dahir, K. M. Dahir, K.M. Dahir, Kathryn Dahir, Kathryn M Dahir, Kathryn M. Dahir, Kathryn McCrystal Dahir, Kathryn M Dahir

102

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Medical Center Duke Medical Center Alexion Pharmaceuticals (United States)University of Würzburg Vanderbilt University

About

Kathryn Dahir is an author at Vanderbilt University Medical Center specializing in medicine, osteoporosis, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	217
2	Nephrology	2	2	44
3	Health Sciences	1	1	13
4	Social Sciences	1	1	57
5	Endocrinology	1	1	21

Kathryn Dahir

Publications

837

Citations

H-Index

Page 1

	Year	Citations
Burden of Illness in Adults With Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry Lothar Seefried, Kathryn Dahir, Anna Petryk, Journal of Bone and Mineral Research	2020	83
Neurological symptoms in Hypophosphatasia Juan M. Colazo, Jiun‐Ruey Hu, Kathryn Dahir, Osteoporosis International NeuropsychologyNeurological DisorderNeuroanatomyNeurological SymptomsNeurology	2018	57
Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience Kathryn Dahir, María Belén Zanchetta, Irinel Stanciu, Journal of the Endocrine Society	2021	56
The Global ALPL gene variant classification project: Dedicated to deciphering variants Mariam R. Farman, Catherine Rehder, Theodora Malli, Bone	2023	54
New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6 Michael P. Whyte, William H. McAlister, Fan Zhang, Bone New ExplanationBone Morphogenic ProteinGenetic EpidemiologyPathologyBone Homeostasis	2019	51
Clinical profiles of treated and untreated adults with hypophosphatasia in the Global HPP Registry Kathryn Dahir, Lothar Seefried, Priya S. Kishnani, Orphanet Journal of Rare Diseases	2022	48
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial Maja Di Rocco, Eduardo Forleo‐Neto, Robert J. Pignolo, Nature Medicine	2023	45
Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia Lothar Seefried, Priya S. Kishnani, Scott Moseley, Bone	2020	37
Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program Eric T. Rush, Britt Johnson, Swaroop Aradhya, Journal of Bone and Mineral Research	2020	34
Health Care Transition From Pediatric- to Adult-Focused Care in X-linked Hypophosphatemia: Expert Consensus Kathryn Dahir, Ruban Dhaliwal, Jill H. Simmons, The Journal of Clinical Endocrinology & Metabolism	2021	34

Page 1